BUZZ-Nicox: Plunges after FDA set to inspect partner's production facility

Fri Jul 22, 2016 3:17am EDT
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

** Shares of French biotech co fall >7 pct after FDA set to inspect latanoprostene bunod production facility

** FDA has raised concerns which pertain to an inspection of the manufacturing facility of Bausch + Lomb, a Nicox partner, and a unit of Valeant

** Valeant says some deficiencies were identified by the FDA at Bausch + Lomb's production facility in Tampa, FL

** Shares were down as much as 16.6 pct minutes after open before trading was halted

** Stock top faller on French health care index